Back to dashboard
CommercialCoverageLow impact

08.01.85b, Tebentafusp-tebn (Kimmtrak®)

Independence Blue Cross·Oncology·Pharmacy
Effective date
Nov 26, 2025
We identified it
Jun 19, 2026
Days to comply
—

Summary

Commercial insurance policy for Tebentafusp-tebn (Kimmtrak®), a pharmacy benefit drug, has been reissued with an effective date of November 26, 2025. This appears to be an updated policy for this specialized oncology medication used to treat uveal melanoma.

Action Required

Action needed
By November 26, 2025: Billing team should review the full policy details at the provided URL to understand any changes to coverage, prior authorization requirements, or billing procedures for Tebentafusp-tebn (Kimmtrak®). Since only summary information is provided, access the complete policy to determine specific billing impacts.

Related policy hubs